University Hospital Coventry and Warwickshire: Substantive Consultant Advertising Post
Call for experts : WHO Technical Advisory Group on Measurement Monitoring & Evaluation of UN Decade of Healthy Ageing (2021-2030)
We are pleased to inform you that the call for experts for the WHO Technical Advisory Group on Measurement, Monitoring and Evaluation of UN Decade of Healthy Ageing (2021-2030) has been published on the WHO website. Please find here the weblink: Call for Experts .
WHO Technical Advisory Group (TAG) on Measurement, Monitoring and Evaluation of UN Decade of Healthy Ageing (2021-2030) will provide advice to WHO on the measurement, monitoring and evaluation of the UN Decade of Healthy Ageing (2021–2030) and programmes related to the action areas.
The Technical Advisory Group (TAG) on Measurement, Monitoring and Evaluation of UN Decade of Healthy Ageing (2021-2030) will be expected to meet annually at least twice virtually or in person at WHO Headquarters in Geneva, Switzerland, usually for 2-3 days each time. Interim teleconferences may be required of the members. The working language of the group will be English.
The TAG will be multidisciplinary, with members who have a range of technical knowledge, skills and experience relevant to epidemiology, geriatrics, gerontology, sociology, anthropology, economy and related specialties such as environmental gerontology, demography, community development, and statistics in relation to the Decade’s priority action areas. Approximately 20 members may be selected.
Members of the TAG must have excellent technical knowledge at least some of the following areas:
- Epidemiology of ageing and health;
- Methods for producing global health estimates related to ageing indicators, including engagement with stakeholder groups;
- Monitoring and evaluation of programmes towards longer and healthy lives of older persons ;
- Health information systems;
- Operationalization and validation of indicators or development of new measure.
If you have any questions about this “Call for experts”, please write to TAG Secretariats Dr Amuthavalli Thiyagarajan Jotheeswaran (email : amuthavallithiya(at)who.int) and Dr Mikton Christopher (email: miktonc(at)who.int) well before the applicable deadline.
The deadline for application is 30 September 2021 [24:00h (midnight) Geneva time].
Thank you very much.
Postdoctoral Researcher in Geriatric Epidemiology at Karolinska Institutet
Aging Research Center (ARC), a division within NVS, is located at KI Campus Solna, Stockholm. Together with medical doctors, epidemiologists, biostatisticians and clinical researchers, the candidate will contribute to two EU funded projects starting in late spring 2021 led at Karolinska Institutet by Assistant Professor Davide L Vetrano. Both projects are focused on the investigation of multimorbidity in older adults: AFFIRMO (Atrial fibrillation integrated approach in frail, multimorbid and polimedicated older people) and I-CARE4OLD (Individualized care for older persons with complex chronic conditions in home care and nursing homes).
Please find hereafter the link with more details on the "Job Opportunity"
Post-doc positions at the Gérontopôle of Toulouse
Full Proposal here
The Toulouse Gérontopôle, led by Prof Bruno VELLAS, within the framework of the INSPIRE project, has the opportunity of funding a Post-Doc or a Doc position, or an invited research scientist, or a M.D to work on databases and publications.
Expertise in statistics will be needed, as well as on the related topic.
Institute on Aging
Gérontopôle - Toulouse University Hospital
c/o Faculté de Médecine, Bât B, 37 Allées Jules Guesde, 31000 Toulouse, France
Tel : +33 (0) 22.214.171.124.39 - Fax : +33 (0) 126.96.36.199.40
INSPIRE websites :
in French : https://inspire.chu-toulouse.fr/fr/
in English : https://inspire.chu-toulouse.fr/en/
Twitter : @INSPIREPlatfor1
Call for expressions of interest to join DARWIN EU Advisory Board
HMA AND EMA are pleased to invite you to express your interest to joing the DARWIN EU Advisory Board
The mandate of the DARWIN EU advisory board includes one patient/consumer and one healthcare professional representative.
We hereby invite those interested to express interest, together with an outline of activities or experience you and/or your organisation has in the field of real world data & data analysis.
Please send your expressions of interest to us by 5th May 2021.
The Phase II report of the HMA-EMA joint Big Data Task Force outlines ten priority recommendations to evolve data-driven regulation, facilitating the development, authorisation and supervision of medicines.
The first of these recommendations is to put in place the capability to enable access to, and analysis of healthcare data from across the EU to support regulatory decision-making on medicines.
This capability is termed the Data Analysis and Real-World Interrogation Network – DARWIN EU. It will:
- Establish the DARWIN EU Coordination Center and related contractual services as well as connectivity to the European Health Data Space
- Conduct scientific studies to research questions supporting regulatory decision-making by the EMA scientific committees and the broader EU Medicines Regulatory Network;
- Maintain a catalogue of Real-World Data sources for use in the regulatory context and their metadata.
The focus of DARWIN EU will be on Real World Data (RWD) including electronic health records and health insurance data (data from primary, secondary and/or hospital care).
Further information on the DARWIN EU regulatory use cases can be found in Annex I.
DARWIN EU Advisory Board
The mandate of the DARWIN EU Advisory Board was adopted by the Heads of Medicines Agencies and the EMA Management Board in March 2021 (attached). In brief, it will:
- Provide strategic advice and recommendations to the project team on the establishment of the DARWIN EU capability and its use of the European Health Data Space;
- Ensure continued coordination and alignment of the project with relevant European initiatives and policy as well as Member state initiatives; and
- Support two-way communication on DARWIN EU with the EU Regulatory Network, stakeholders and the European Health Data Space.
The Board will meet bi-monthly and we anticipate its meetings to last approximately 90-minutes. In addition, members will likely wish to prepare and may sometimes want to consult colleagues.
The first Advisory Board meeting is expected to take place in May 2021.
Public and Stakeholders Engagement Department
Stakeholders and Communication Division
European Medicines Agency
 The RWD definition adopted by the EMA is 'routinely collected data relating to patient health status or the delivery of health care from a variety of sources other than traditional clinical trials'. This includes data from registries, claims, social media, M-health and electronic health records
Post-Doc Position at the Centre on Aging and Mobility at the University of Zurich “Delay Biological Aging and Extend Health”
I have the pleasure to share with you an exciting job opportunity at the University of Zurich (Switzerland) (CLICK HERE TO DOWNLOAD). The Center on Aging and Mobility (CAM) is an internationally recognized research center for clinical research on healthy and active aging, sarcopenia and frailty. It is led by Prof. Heike A. Bischoff-Ferrari, MD DrPH.
Do not hesitate to directly liaise with our colleagues if you feel it appropriate.
Please note that future candidates should have a doctoral degree in epidemiology or biostatistics in the field of aging and or nutrition. Fluency in English is required.
Hoping that this proposal will be found of interest by some of you.
Very best regards,
Prof. René Rizzoli
EMA - Call for expression of interest for representatives in EMA's COVID-19 taskforce
EMA has established a taskforce on COVID-19 (ETF) to ensure that all COVID 19-related challenges are handled in the most efficient manner possible. The key aim of the taskforce is to support the Agency’s business continuity following the outbreak of COVID-19.
Since its inception the ETF has taken a leading role in providing advice to companies developing medicines and vaccines for COVID-19, evaluating data on medicines used for COVID-19 and supporting EMA’s human medicines committee (CHMP) in its evaluations. The EFT has also carried assessment underpinning EMA advice to the public.
It is clear that in this crisis context, engagement with patients and healthcare professionals is more important than ever, and for this reason EMA would like to appoint one patient/consumer representative and one healthcare professional representative to actively participate in ETF meetings. The representatives would provide input and bring views from the communities they represent on specific aspects of ETF work during the pandemic while also helping to disseminate vital public health messages to increase transparency, awareness and understanding of COVID-19 regulatory activities.
In terms of expected timing and workload, the task force usually has two 2-hour long meetings per week – one for vaccines and one for therapeutics. However as a starting point, both representatives would only attend selected ETF meetings (or part of a meeting) where it is expected that their input would be most relevant and valuable. This format will be monitored and adjusted as needed, based on experience. EMA colleagues will fully support their participation.
One representative and one alternate will be selected according to the following criteria:
· Be a member of an EMA eligible organisation;
· Be familiar with drug development, regulatory processes and the legal Community framework affecting medicines;
· Ideally have knowledge or experience in the area of vaccines, infectious diseases, internal medicine, primary care, respiratory diseases or intensive care.
· Have the capacity to participate and contribute to ETF activities
· Have a valid DOI and confidentiality undertaking, assessed to the level of committee member (can be done after appointment)
We welcome expressions of interest, together with a brief motivation outlining relevant experience in relation to COVID-19, by 24 July 2020, by email to the following address: public-engagement(at)ema.europa.eu
EMA - Call for expression of interest for nomination of experts to participate in a virtual meeting on “Artificial intelligence in clinical trials – ensuring it is fit for purpose” (22 September 2020)
The EMA Inspections Office together with the Good Clinical Practice Inspectors Working Group (GCP-IWG) is seeking to identify patients and healthcare professional experts who could share their experience with the use of artificial intelligence (AI) in the medical field, particularly to discuss practical use cases and challenges validating AI tools.
The meeting will take place on 22nd September between 14:30 – 19:15 (CET). This date overlaps with the PCWP/HCPWP session on Pregnancy and lactation, however, we hope you can suggest alternative experts who can join.
Some of the topics to be covered during the meeting include:
· Summary status of current and immediate future use of AI in clinical trials
· Use cases for the use of AI in clinical trials
· The validation of AI in clinical research and other related fields
· Risk assessment and considerations
· AI and “fit for purpose”
· Perceived challenges by regulators and industry
For that purpose, we are now launching a call for expressions of interest to identify potential candidates and a decision will then be made by the Agency’s Inspections Office together with members of the GCP-IWG.
Experts interested in joining the meeting are kindly asked to send us a short (no more than 150 words) CV indicating their expertise on the topics discussed. This is to ensure we can also cope with the limitations on number of participants imposed by the Adobe Connect virtual room capacity.
Please send your expression of interest, together with your motivation to public-engagement(at)ema.europa.eu by Friday, 24 July 2020.
Recruitment advertising NHS Greater Glasgow and Clyde , Scotland
NHS Greater Glasgow and Clyde is the largest NHS Health Board in Scotland and one of the largest in the UK.
They are seeking to recruit 4 Geriatric Consultant post across several specialties.
For further information please visit :
Consultant in Geriatric Medicine (General with Geriatric Orthopaedic Rehabilitation Unit - GORU) , Vale of Leven Hospital
Consultant in Geriatric Medicine (Older Adult and Frailty) , Royal Alexandria Hospital
Consultant in Geriatric Medicine (Movement Disorder), Inverclyde Royal Hospital
Consultant in Geriatric Medicine (Orthogeriatrics), Inverclyde Royal Hospital
WORLD HEALTH ORGANIZATION - Call for Part-time Tutors for Online Course on Healthy Ageing
The World Health Organization is looking for tutors to help support the delivery of the first ever WHO learning programme on Healthy Ageing.
This online course equips participants with the competencies and skills needed to engage meaningfully with the topic of Healthy Ageing and to become change agents for the Decade of Healthy Ageing.
If you know of someone who is passionate about ageing and available to work remotely on a part-time basis, please encourage them to read this opportunity – link here: https://www.who.int/ageing/healthy-ageing-tutor-TOR.pdf?ua=1.
Interested candidates will need to send a single file including both their CV/resume and a letter of interest to the course coordinator, Dr de la Fuente-Núñez at the following email address: email@example.com. The application deadline is 23:59 UTC + 02:00 on 8 May 2020.
No email inquiries please. Only complete applications will be reviewed, and only shortlisted candidates will be contacted further.
Chair in geriatric medicine at Sheffield
The University of Sheffield is seeking to recruit a Chair in geriatric medicine / frailty within the Faculty of Medicine. This person would be joining our Flagship University Institute - HELSI (Healthy Lifespan Institute:
Individuals interested in such a position, either from the UK or internationally, would ideally be a rising star ready to move into a Chair, but we may consider appointing to Senior Lecturer or Reader posts. We would be interested in talking to clinical academics who have health services research expertise but also interests and track record in bench research.
For contacts: Prof. Suzanne M Mason firstname.lastname@example.org
Professor of Emergency Medicine
School of Health and Related Research
University of Sheffield
New Position - additional Chair in Geriatric Medicine, University of Aberdeen, UK
The EuGMS is happy to disseminate an exciting opportunity for an academic geriatrician looking for a new challenge.
You will see from the link below the University of Aberdeen has created a new post, a second Chair of Geriatric Medicine and applications are now invited.
Informal enquiries are very welcome either to the Head of School as advertised or to Prof Roy SOIZA (NHS GRAMPIAN) roy.soiza(at)nhs.net.
A new PhD position is available in our group (Lille, France)
A new PhD position is available in our group (Lille, France). The title of the project is "Effects of early-life and chronic exposure to dietary AGEs on chronic, low-grade inflammation and age-associated disorders"
To apply, students can follow the pertinent instruction on the following link :
Prof. Éric BOULANGER (MD, PhD)
Aging Biology & Geriatrics @ Medical School-INSERM-University Hospital of Lille
Vacancy notices - Vaccine-preventable diseases and Immunization - WHO EURO
The EuGMS has the pleasure to announce two (2) vacancy notices within the Vaccine-preventable diseases and Immunization unit in the WHO European Regional Office (P5 Team Lead-Immunization and VPD Surveillance Data and, P4 Vaccine Quality and Safety).
Doctoral and/or Post-doctoral positions for the INSPIRE Project at the Gérontopôle of Toulouse
The Institute looks forward to receiving the potential candidate's material (in english) such as:
- A brief cover letter (max 1 page) explaining why he/she would like to join the Gérontopôle
- A short Curriculum Vitae including list of publications
- The pdf file of one or two full-text articles
- E-mail and contact number for a possible phone interview
Position of MD attendee of geriatric area with dedication to practice and research in Barcelona (13.08.2018)
Parc Sanitari Pere Virgili is looking for a physician with a research trajectory.
Download the proposal here.